Home | Welcome to Contract Pharma   
Last Updated Sunday, August 31 2014
Print RSS Feed

Search Results for 'tablets'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Contract Service Directory Categories

View All Categories »


Search Results:

By Gil Roth
Published June 22, 2011
Cancels NDA and MAA and withdraws MS treatment from approved markets Read More »
Metal Contamination in Bio- pharmaceutical Drugs
By Mary Stellmack and Dr. Kent Rhodes
Published October 8, 2010
Solving a puzzle without all the pieces Read More »
Published July 28, 2010
EMD Serono’s NDA for Cladribine Tablets has accepted for filing as a therapy for relapsing forms of multiple sclerosis (MS). Read More »
Published February 12, 2010
Abbott received approval from the FDA for a new tablet formulation of antiretroviral drug Norvir (ritonavir). Read More »
Published January 2, 2007
Ranbaxy Laboratories has received approval from the FDA to manufacture and market Atenolol Tablets USP, 25 mg, 50 mg, and 100 mg. The Office of Generic Drugs, U.S. FDA, has determined the Ranbaxy formulations to be bioequivalent and have the same the… Read More »
Published August 19, 2014
To develop novel formulations to enhance bioavailability Read More »
Published April 3, 2014
Kemwell expands lyophilization capacity Read More »
By Kevin Lesnewski, Manager, Marketing & Business Intelligence
Vifor Pharma - Vifor Ltd.
By Delphine Galaud
Vifor Pharma is a Swiss Pharmaceutical company (member of the Galenica Group) mainly active in formulation and production of Rx and OTC pharmaceutical products expanding internationally. Vifor Pharma also offers a customized approach of manufacturing… Read More »
By Courtney Valdeon, Manager, Sales & Operation
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On